NCT06162871

Brief Summary

The research aims to promote active aging through a pilot study. The design will be crossover with two groups. Intervention will consist of presentations and interactive debate sessions, with a central focus on intergenerational exchange covering cultural, historical, and health-related topics. A key aspect is the active involvement of beneficiaries, individuals over sixty-five. The outcomes will be quality of life, presence of depressive symptoms, and regularity of biological and social rhythms.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 8, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

February 11, 2025

Status Verified

February 1, 2025

Enrollment Period

1.2 years

First QC Date

November 30, 2023

Last Update Submit

February 7, 2025

Conditions

Keywords

healthy agingGenerational exchangePsychosocial interventionPilot study

Outcome Measures

Primary Outcomes (7)

  • Change from Baseline to post treatment and to follow-up of The Short Form Health Survey (Quality of life)

    To evaluate it will be used: The Short Form Health Survey (SF-12), a brief version of SF-36 questionnaire, made up of twelve questions, values range from 12 to 47, includes the following dimensions: physical activity, disturbance in physical health, physical condition, self-assessment of health status, vitality, social activity and mental health assessed on a monthly basis . Higher scores recorded a greeting and better Quality of life

    T0 (0 weeks); T1 (12 weeks); T2 (28 weeks)

  • Change from Baseline to post treatment and to follow-up of The Brief Social Rhythms Scale (Social and biological Rhythms)

    To evaluate it will be used: The Brief Social Rhythms Scale (BSRS), a 10 item questionnaire, values range from 10 to 60, designed to assess the level of regularity in biological and social rhythms, specifically those related to sleep-wake cycles and appetite, as well as social contacts. Higher scores recorded a worse regulation of rhythms

    T0 (0 weeks); T1 (12 weeks); T2 (28 weeks)

  • Change from Baseline to post treatment and to follow-up of Patient Health Questionnaire-9 (Depression symptoms)

    To evaluate it will be used: Patient Health Questionnaire-9 (PHQ-9) a short self-administered tool, values range from 0 to 27, used for screening, diagnosis, monitoring and measuring the severity of depression. It's composed of 9 items that correspond to the symptoms of major depression according to DSM-IV on last two weeks. Higher scores identify a greater presence of depressive symptoms.

    T0 (0 weeks); T1 (12 weeks); T2 (28 weeks)

  • Change from Baseline to post treatment and to follow-up of Physical Activity Questionnaire (type and quantity of physical activity)

    To evaluate it will be used: Physical Activity Questionnaire (IPAQ) designed to measure the type and quantity of physical activity undertaken in the past 7 days, values range from 0 to the maximum amount of minutes a person spends on physical activity or sedentary activities, including occupational and recreational physical activities, through 9 items, on a weekly basis, Higher scores identify in a subscale a frequent physical activity (MET minutes a week). MET minutes represent the amount of energy expended carrying out physical activity.

    T0 (0 weeks); T1 (12 weeks); T2 (28 weeks)

  • Change from Baseline to post treatment and to follow-up of Addenbrooke's Cognitive Examination (Cognitive performance)

    To evaluate it will be used: Addenbrooke's Cognitive Examination (ACE-R), a brief cognitive test, values range from 0 to 100, that assesses five cognitive areas: attention/orientation, memory, verbal fluency, language, and visuo-spatial abilities. The test incorporates the Mini Mental State Examination (MMSE). The higher the score obtained in the test, the lower the presence of signs that identify cognitive deterioration on the screening performance scales

    T0 (0 weeks); T1 (12 weeks); T2 (28 weeks)

  • Evaluation of the Feasibility of the intervention with Dropout rate at post intervention time

    To evaluate it will be used: Dropout rate (25% dropout in the sample will be considered acceptable considering that it is a group of elderly people)

    at T1 (12 weeks)

  • Intervention satisfaction at post intervention time

    Intervention satisfaction questionnaire (it will be considered a satisfactory level if on average the intervention is rated by the participants one standard deviation above the average of the ad hoc questionnaire)

    at T1 (12 weeks)

Study Arms (2)

active participation

EXPERIMENTAL
Behavioral: Presentations and interactive debate sessions, with intergenerational exchange

non involved in active part

NO INTERVENTION

Interventions

Intervention will consist of 12 sessions, each lasting about two hours, conducted on a weekly basis and delivered both in-person and remotely. The sessions will include presentations and interactive debate sessions, with a central focus on intergenerational exchange covering cultural, historical, and health-related topics. A key aspect is the active involvement of beneficiaries, individuals over sixty-five, who will be asked to prepare presentations with the support of project-provided facilitators. Simultaneously, the project will promote and enhance skills, organizational capabilities, and computer literacy.

active participation

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • people who are 65 years of age or older

You may not qualify if:

  • have serious problems with independent walking,
  • have serious neurological conditions or serious disabilities that make it impossible to participate in the intervention in person or remotely

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

San Giovanni di Dio Hospital

Cagliari, CA, 09100, Italy

Location

Related Publications (1)

  • Cossu G, Lorrai S, Galetti A, Perra A, Tusconi M, Carra G, Preti A, Holzinger A, Carta MG. Promoting healthy aging through intergenerational exchange and digital empowerment: a pilot randomized controlled trial. Front Psychiatry. 2025 Jul 16;16:1637181. doi: 10.3389/fpsyt.2025.1637181. eCollection 2025.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: The experimental condition in the experimental group consists of a psychosocial intervention. The control group is initially inactive and after the experimental group post treatment will be involved in the experimental intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 30, 2023

First Posted

December 8, 2023

Study Start

December 1, 2023

Primary Completion

February 1, 2025

Study Completion

June 1, 2025

Last Updated

February 11, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations